Zarondan-Saft en es it fr

Zarondan-Saft Brand names, Zarondan-Saft Analogs

Zarondan-Saft Brand Names Mixture

  • No information avaliable

Zarondan-Saft Chemical_Formula

C7H11NO2

Zarondan-Saft RX_link

http://www.rxlist.com/cgi/generic2/ethosuximide.htm

Zarondan-Saft fda sheet

Zarondan-Saft FDA

Zarondan-Saft msds (material safety sheet)

Zarondan-Saft Synthesis Reference

No information avaliable

Zarondan-Saft Molecular Weight

141.168 g/mol

Zarondan-Saft Melting Point

64.5 oC

Zarondan-Saft H2O Solubility

39.2 g/L

Zarondan-Saft State

Solid

Zarondan-Saft LogP

1.012

Zarondan-Saft Dosage Forms

Syrup

Zarondan-Saft Indication

For the treatment of petit mal epilepsy.

Zarondan-Saft Pharmacology

Used in the treatment of epilepsy. Ethosuximide suppresses the paroxysmal three cycle per second spike and wave activity associated with lapses of consciousness which is common in absence (petit mal) seizures. The frequency of epileptiform attacks is reduced, apparently by depression of the motor cortex and elevation of the threshold of the central nervous system to convulsive stimuli.

Zarondan-Saft Absorption

No information avaliable

Zarondan-Saft side effects and Toxicity

No information avaliable

Zarondan-Saft Patient Information

No information avaliable

Zarondan-Saft Organisms Affected

Humans and other mammals